Slide 1: Cellebrite to Merge with TWCT
Cellebrite to Merge with TWCT April 8, 2021 Cellebrite Internal & Confidential
Slide 2: Caution Regarding Forward Looking Statements
Caution Regarding Forward Looking Statements This document includes “forward looking statements” within the meaning of the “safe harbor” provisions of the United States P riv ate Securities Litigation Reform Act of 1995. Forward - looking statements may be identified by the use of words such as “for
Slide 3: Announcement Overview
Announcement Overview Who Cellebrite intends to merge with a special purpose acquisition company (“ SPAC ”) called TWC Tech Holdings II Corp. (“ TWCT ”) What $480 million expected gross cash proceeds; pro forma equity value of approximately $2.4 billion $300 million fully - committed oversubscribed
Slide 4: What is a SPAC? About TWCT sponsor
• Private equity firm that formed TWCT • Invests in differentiated, leading TMT companies • 30+ platform investments with $75+B in total transaction value and $15+B of invested equity • SPAC investments with Open Lending (NASDAQ: LPRO ) and A Place for Rover (NASDAQ: NEBC ) • Successful prior experi
Slide 5: Why are we going public through a SPAC?
Why are we “going public” through a SPAC? Merging with a SPAC is a streamlined and efficient way for Cellebrite to become a public company and raise additional capital Cellebrite as a Publicly Listed Operating Company Cellebrite TWC Tech Holdings II, Inc. + = Listed SPAC ( TWCT ) Private Company
Slide 6: Investment highlights: Cellebrite by the numbers
Investment highlights Cellebrite by the numbers $12B+ TAM (2023) ~$200M ARR (2021E) 50% ARR Growth (2020A) 99% Win Rate 1 140%+ ARR Net Dollar Retention 3 ~80% Gross Margin 2 ~20% EBITDA Margin 2 Undisputed leader in investigative Digital Intelligence (“DI”) Top research team built from elite Israel
Slide 7: How does Cellebrite intend to use the additional capital?
How does Cellebrite intend to use the additional capital? x Execute on significant near - term growth opportunities in the public sector x Develop new customer solutions x Expand private sector and end - market reach Reinforces Cellebrite’s Position as the Global Leader in Digital Intelligence Solut
Slide 8: Significant near-term growth opportunity
Significant near - term growth opportunity Net new expansion M&A Private sector growth New and extended offering 5x 1 increase in spend on in - house discovery and investigations Targeted, disciplined approach Premium Enterprise Cloud & SaaS Remote Collection New buying centers within existing logos
Slide 9: What happens next?
What happens next? File documents with SEC Regulatory approval process Other closing conditions satisfied Cellebrite listed on Nasdaq CLBT
Slide 10: What will change once Cellebrite is a public company?
What will change once Cellebrite is a public company? Stock to trade on Nasdaq under the CLBT ticker symbol Cellebrite will be subject to reporting and disclosure requirements Management, reporting lines and office locations will not change Employee base compensation and benefits will not change For
Slide 11: Where can we get more information?
Where can we get more information? CelleConnect Cellebrite Investor Page on https://www.cellebrite.com/en/investors Company Updates Please send your questions to employee.questions@cellebrite.com Forward external media and industry analyst inquires to RapidResponse@cellebrite.com